A new breast cancer drug has been unveiled to help women in the late stages of the disease. Known as T-DM1-, it combines the antibody Herceptin with a chemotherapy agent to seek out cancerous cells.
Please wait while this video loads. If it doesn't load after a few seconds you may need to have Adobe Flash installed.
Article Tags
-
Risks of breast cancer over-diagnosis 'not made clear'
01 September 2011 -
Breast cancer genetic code mapped
24 February 2012
